News | March 25, 2026
ImmunityBio scores first Asian approval for ANKTIVA in Macau
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
Pfizer recommends that shareholders do not tender their shares in response to Tutanota’s offer
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
Launches advanced bone density systems in India & Dubai
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Subscribe To Our Newsletter & Stay Updated
